Vivek Subbiah, Chief of Early-Phase Drug Development at Sarah Cannon Research Institute, shared a post on LinkedIn he and colleagues co-authored, published in Nature Medicine.

“Delighted to share our paper published in Nature Medicine ‘Cancer treatment paradigms in the Precision Medicine era.’

To fully harness precision medicine and transform cancer care for the better will require a strategic shift to highly personalized interventions that embrace innovation and adaptability.”

Title: Cancer treatment paradigms in the precision medicine era

Authors: Vivek Subbiah, Giuseppe Curigliano, Jason K. Sicklick, Shumei Kato, Kjetil Tasken, Arielle Medford, Damian T. Rieke, Hui-Zi Chen, Adam Wahida, Lars Buschhorn, Denis Horgan, Razelle Kurzrock

Read The Full Article at Nature Medicine.

Vivek Subbiah: What is Missing to Fully Harness Precision Medicine and Transform Cancer Care

More posts featuring Vivek Subbiah on OncoDaily.